URGN Operating Income Growth

Urogen Pharma Ltd · Operating Income Growth

URGN logo

URGN Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported46.06%
URGN TTM Operating Income YoY % (106.22% → 46.06%)
High-resolution chart · PNG

URGN operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Urogen Pharma Ltd Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
46.0583%
-0.2371%
-29.0147%
-59.3231%
-55.061%
-55.9359%
-47.6776%
-17.5877%
-5.1348%
12.5087%
17.0861%
9.4885%
9.7957%
10.2184%
14.3577%
21.0346%
20.2136%
22.8861%
27.1795%
28.4897%
21.2027%
9.0075%
-15.7666%
-48.7614%
-46.4017%
-46.0994%
-41.8476%
-47.9067%
-114.628%
-186.0808%
-286.8672%
-1,641.0319%
-2,405.0059%
-3,602.5641%
-2,600%
120.4774%
89.3809%
106.2219%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.